September 26, 2013
…organization committed to stopping Alzheimer’s by 2020. Proceeds from the performance benefit the UC San Diego Shiley-Marcos Alzheimer’s Disease Research Center and WomenAgainst Alzheimer’s – the first national network of women in leadership positions working to speed the pace of research and build momentum to end Alzheimer’s disease. “Through my…
May 15, 2012
Researchers at the Comprehensive Alzheimer’s Program at the University of California, San Diego School of Medicine have announced two new clinical trials for patients with either mild to moderate Alzheimer’s disease (AD) and one trial for Mild Cognitive Impairment.
August 15, 2012
Sticky plaques of proteins called amyloids mark several different, though related degenerative brain diseases including Alzheimer’s, Parkinson’s and Creutzfeld-Jacobs. The symptoms of these disorders overlap and methods to diagnose and monitor them are not very advanced.
July 3, 2019
On July 1, 2019, USC and UC San Diego reached a settlement in the ongoing Alzheimer’s disease research lawsuit, Regents of the University of California v. Aisen et al.
December 5, 2017
…brain function and memory in a mouse model of Alzheimer’s disease. The molecule, called anle138b, works by stopping toxic ion flow in the brain that is known to trigger nerve cell death. Scientists envision that this drug could be used to treat Alzheimer’s and other neurodegenerative diseases such as Parkinson’s…
January 13, 2016
…of California, San Diego School of Medicine and the Alzheimer’s Disease Cooperative Study (ADCS), in collaboration with AC Immune, a biotechnology company based in Switzerland, will test the safety and tolerability of an immunotherapy vaccine that targets Alzheimer’s disease-like characteristics in adults with Down syndrome.
November 21, 2023
UC San Diego’s Center for Scientific Computation in Imaging has received a $7.5 million grant from the National Institutes of Health to continue its interdisciplinary exploration of diffusion magnetic resonance imaging (dMRI) work related to Alzheimer’s disease.
November 13, 2020
UC San Diego researchers have identified new mechanisms in neurons that cause Alzheimer’s disease. In particular, they discovered that structural changes in chromatin trigger neurons to lose their specialized function and revert to a precursor-like state.
March 19, 2013
Researchers at the University of California, San Diego School of Medicine are principal investigators in two of nine new grants approved today by the governing board of the California Institute for Regenerative Medicine (CIRM).
August 21, 2023
New results from researchers at UC San Diego School of Medicine suggest that intermittent fasting could be an effective treatment approach for Alzheimer’s disease. Mice fed on a time-restricted schedule had better memory and less accumulation of amyloid proteins in the brain compared to controls.
